You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
信立泰(002294.SZ):高瓴祈翼、高瓴祈睿擬合計3億元投資錦江電子
格隆匯 11-29 22:29

格隆匯11月29日丨信立泰(002294.SZ)公佈,四川錦江電子科技有限公司(“錦江電子”或“標的公司”)系公司全資子公司深圳市信立泰生物醫療工程有限公司(“生物醫療”)的參股公司,生物醫療持有錦江電子19.3199%股權。

為支持錦江電子引入新投資者,生物醫療擬將持有的錦江電子合計1.3889%股權轉讓給珠海祈翼企業管理諮詢中心(有限合夥)(“高瓴祈翼”)、蘇州高瓴祈睿醫療健康產業投資合夥企業(有限合夥)(“高瓴祈睿”),股權轉讓款合計人民幣5000萬元。

同時,錦江電子現有股東李楚森擬向高瓴祈翼、高瓴祈睿轉讓其持有的錦江電子合計1.3889%股權,交易對價為人民幣5000萬元;此後高瓴祈翼、高瓴祈睿擬以人民幣2億元向錦江電子增資,獲得增資後錦江電子4.7619%股權。生物醫療擬放棄前述轉讓股權的優先購買權以及增資的優先認繳權。

交易前,生物醫療持有錦江電子19.3199%股權;交易完成後,生物醫療將持有錦江電子17.0772%股權。

公吿顯示,錦江電子成立於2002 年,主要從事心臟電生理領域醫療器械的研發、生產、銷售。交易前後股東及持股比例如下:

次轉讓參股公司錦江電子股權放棄優先權,系出於支持錦江電子引入投資者、進一步充實資本實力的考慮同時,生物醫療也將獲得合理投資回報,符合投資預期獲得的相關投資收益將投入公司研發、生產等主營業務,符合公司長遠發展利益及戰略發展規劃。

若完成此次股權轉讓預計產生投資收益3200萬元(最終以經審計的財務報表數據為準),對公司本期及未來的財務狀況和經營成果產生一定積極影響。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account